Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX $195.00)
- $195.00 P/E (TTM): 37.94X Cap: $56.16B
- View BDX Profile
- View Questions on BDX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $481.28)
- $481.28 P/E (TTM): 66.89X Cap: $172.16B
- View ISRG Profile
- View Questions on ISRG
Abbott Laboratories (ABT $130.27)
- $130.27 P/E (TTM): 16.53X Cap: $229.30B
- View ABT Profile
- View Questions on ABT
Becton Dickinson and Company (BDX $195.00)
- $195.00 P/E (TTM): 37.94X Cap: $56.16B
- View BDX Profile
- View Questions on BDX
Boston Scientific Corporation (BSX $103.05)
- $103.05 P/E (TTM): 61.41X Cap: $152.87B
- View BSX Profile
- View Questions on BSX
iShares U.S. Medical Devices ETF (IHI $61.63)
- $61.63 P/E (TTM): 164.7X Cap: $4.32B
- View IHI Profile
- View Questions on IHI

Q: Comments on earnings and if buy, sell or hold. What is happening with medical devices in the current economic environment? Thank you!

Read Answer Asked by Neil on May 06, 2025

Intuitive Surgical Inc. (ISRG $481.28)
- $481.28 P/E (TTM): 66.89X Cap: $172.16B
- View ISRG Profile
- View Questions on ISRG
Becton Dickinson and Company (BDX $195.00)
- $195.00 P/E (TTM): 37.94X Cap: $56.16B
- View BDX Profile
- View Questions on BDX
Stryker Corporation (SYK $381.61)
- $381.61 P/E (TTM): 50.58X Cap: $146B
- View SYK Profile
- View Questions on SYK

Q: Team, I have holdings in all three and although I have done great with BDX over the years, it seems to be struggling. I am thinking of selling but would like your comments on increasing my holdings in SYK and ISRG or would you provide insights another option. All three stocks are in my non registered account.
By the way, because of your insights on AMED of a few years ago, I sold the stock and purchased GOOG.............it was a great move
I have whittled down my holdings to 15 stocks and want to be careful adding more

Read Answer Asked by Roland on December 02, 2024

Abbott Laboratories (ABT $130.27)
- $130.27 P/E (TTM): 16.53X Cap: $229.30B
- View ABT Profile
- View Questions on ABT
Becton Dickinson and Company (BDX $195.00)
- $195.00 P/E (TTM): 37.94X Cap: $56.16B
- View BDX Profile
- View Questions on BDX
Stryker Corporation (SYK $381.61)
- $381.61 P/E (TTM): 50.58X Cap: $146B
- View SYK Profile
- View Questions on SYK
GE HealthCare Technologies Inc. (GEHC $73.17)
- $73.17 P/E (TTM): 15.01X Cap: $33.51B
- View GEHC Profile
- View Questions on GEHC

Q: Thoughts on BDX. Healthcare in general has been lagging the market and this company has not produced many gains over the years. Is it time to move on and reallocate money to new area like Quanta Services?

Read Answer Asked by Neil on November 26, 2024